HLS Therapeutics (TSX:HLS) Other Current Liabilities : C$10.33 Mil (As of Mar. 2024)

View and export this data going back to 1959. Start your Free Trial

What is HLS Therapeutics Other Current Liabilities?

HLS Therapeutics's other current liabilities for the quarter that ended in Mar. 2024 was C$10.33 Mil.

HLS Therapeutics's quarterly other current liabilities increased from Sep. 2023 (C$7.72 Mil) to Dec. 2023 (C$9.59 Mil) and increased from Dec. 2023 (C$9.59 Mil) to Mar. 2024 (C$10.33 Mil).

HLS Therapeutics's annual other current liabilities increased from Dec. 2021 (C$5.60 Mil) to Dec. 2022 (C$6.55 Mil) and increased from Dec. 2022 (C$6.55 Mil) to Dec. 2023 (C$9.59 Mil).

HLS Therapeutics Other Current Liabilities Historical Data

The historical data trend for HLS Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLS Therapeutics Other Current Liabilities Chart

HLS Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Liabilities

Get a 7-Day Free Trial

HLS Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Current Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

HLS Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

HLS Therapeutics Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of HLS Therapeutics's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

HLS Therapeutics (TSX:HLS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HLS Therapeutics Inc (TSX:HLS) » Definitions » Other Current Liabilities

Comparable Companies

Traded in Other Exchanges

HLTRF:USA

Address

10 Carlson Court, Suite 701, Etobicoke, ON, CAN, M9W6L2

Website

https://www.hlstherapeutics.com

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company products include Clozaril, Vascepa, Trinomia, and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States, and the Rest of the world.

Executives

Polar Asset Management Partners Inc.

10% Security Holder

HLS Therapeutics (TSX:HLS) Headlines

No Headlines